nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—ABCC1—Dactinomycin—ocular cancer	0.653	1	CbGbCtD
Idarubicin—Radiation injury—Dactinomycin—ocular cancer	0.0316	0.191	CcSEcCtD
Idarubicin—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.0202	0.122	CcSEcCtD
Idarubicin—Recall phenomenon—Dactinomycin—ocular cancer	0.0191	0.115	CcSEcCtD
Idarubicin—Fluid overload—Carboplatin—ocular cancer	0.0144	0.0867	CcSEcCtD
Idarubicin—Extravasation—Carboplatin—ocular cancer	0.0102	0.0618	CcSEcCtD
Idarubicin—TOP2A—G0 and Early G1—E2F5—ocular cancer	0.00819	0.0451	CbGpPWpGaD
Idarubicin—TOP2A—G0 and Early G1—MYBL2—ocular cancer	0.00803	0.0442	CbGpPWpGaD
Idarubicin—TOP2A—G0 and Early G1—E2F4—ocular cancer	0.00803	0.0442	CbGpPWpGaD
Idarubicin—TOP2A—G0 and Early G1—RBL1—ocular cancer	0.00787	0.0433	CbGpPWpGaD
Idarubicin—Phlebitis—Carboplatin—ocular cancer	0.00752	0.0454	CcSEcCtD
Idarubicin—TOP2A—G0 and Early G1—RBL2—ocular cancer	0.00723	0.0398	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 1—MYBL2—ocular cancer	0.00713	0.0392	CbGpPWpGaD
Idarubicin—Myelosuppression—Dactinomycin—ocular cancer	0.00707	0.0427	CcSEcCtD
Idarubicin—TOP2A—G0 and Early G1—RBBP4—ocular cancer	0.00683	0.0376	CbGpPWpGaD
Idarubicin—TOP2A—G0 and Early G1—CDC25A—ocular cancer	0.00649	0.0357	CbGpPWpGaD
Idarubicin—TOP2A—G0 and Early G1—TFDP1—ocular cancer	0.00635	0.0349	CbGpPWpGaD
Idarubicin—Febrile neutropenia—Dactinomycin—ocular cancer	0.00551	0.0333	CcSEcCtD
Idarubicin—Necrosis—Dactinomycin—ocular cancer	0.00422	0.0255	CcSEcCtD
Idarubicin—Extravasation—Dactinomycin—ocular cancer	0.0038	0.0229	CcSEcCtD
Idarubicin—TOP2A—G0 and Early G1—HDAC1—ocular cancer	0.00369	0.0203	CbGpPWpGaD
Idarubicin—Ulcer—Dactinomycin—ocular cancer	0.0035	0.0212	CcSEcCtD
Idarubicin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA11—ocular cancer	0.0035	0.0193	CbGpPWpGaD
Idarubicin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNAQ—ocular cancer	0.00325	0.0179	CbGpPWpGaD
Idarubicin—Infection—Carboplatin—ocular cancer	0.00316	0.0191	CcSEcCtD
Idarubicin—TOP2A—G0 and Early G1—E2F1—ocular cancer	0.00303	0.0167	CbGpPWpGaD
Idarubicin—Oesophagitis—Dactinomycin—ocular cancer	0.00303	0.0183	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.0029	0.016	CbGpPWpGaD
Idarubicin—Sepsis—Dactinomycin—ocular cancer	0.00288	0.0174	CcSEcCtD
Idarubicin—Phlebitis—Dactinomycin—ocular cancer	0.00279	0.0169	CcSEcCtD
Idarubicin—TOP2A—G0 and Early G1—CDK2—ocular cancer	0.00262	0.0144	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.00256	0.0141	CbGpPWpGaD
Idarubicin—Body temperature increased—Carboplatin—ocular cancer	0.00252	0.0152	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00252	0.0138	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00252	0.0138	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.00239	0.0132	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00234	0.0129	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.00213	0.0117	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00212	0.0117	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.00208	0.0115	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.00208	0.0115	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.00204	0.0112	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.00204	0.0112	CbGpPWpGaD
Idarubicin—Pancytopenia—Dactinomycin—ocular cancer	0.00198	0.0119	CcSEcCtD
Idarubicin—Neutropenia—Dactinomycin—ocular cancer	0.00194	0.0117	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.00188	0.0103	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—CRTC1—ocular cancer	0.00186	0.0102	CbGpPWpGaD
Idarubicin—Stomatitis—Dactinomycin—ocular cancer	0.00181	0.0109	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.00177	0.00975	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.00177	0.00975	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.00168	0.00927	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—ID2—ocular cancer	0.00166	0.00911	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.00165	0.00906	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00158	0.0087	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00158	0.00868	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00155	0.00852	CbGpPWpGaD
Idarubicin—Flushing—Dactinomycin—ocular cancer	0.00155	0.00933	CcSEcCtD
Idarubicin—Chills—Dactinomycin—ocular cancer	0.00149	0.00902	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00149	0.00821	CbGpPWpGaD
Idarubicin—Alopecia—Dactinomycin—ocular cancer	0.00147	0.00888	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00136	0.00748	CbGpPWpGaD
Idarubicin—Anaemia—Dactinomycin—ocular cancer	0.00134	0.00809	CcSEcCtD
Idarubicin—Leukopenia—Dactinomycin—ocular cancer	0.0013	0.00783	CcSEcCtD
Idarubicin—Infection—Dactinomycin—ocular cancer	0.00118	0.0071	CcSEcCtD
Idarubicin—Thrombocytopenia—Dactinomycin—ocular cancer	0.00116	0.00699	CcSEcCtD
Idarubicin—Anorexia—Dactinomycin—ocular cancer	0.00113	0.00681	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00112	0.00615	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.00111	0.00612	CbGpPWpGaD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.00111	0.00609	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—MYC—ocular cancer	0.00108	0.00593	CbGpPWpGaD
Idarubicin—Decreased appetite—Dactinomycin—ocular cancer	0.00103	0.00621	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000967	0.00584	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.000965	0.00531	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.000956	0.00526	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.000956	0.00526	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.000937	0.00516	CbGpPWpGaD
Idarubicin—Body temperature increased—Dactinomycin—ocular cancer	0.000935	0.00565	CcSEcCtD
Idarubicin—Abdominal pain—Dactinomycin—ocular cancer	0.000935	0.00565	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.000912	0.00502	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—TP53—ocular cancer	0.000885	0.00487	CbGpPWpGaD
Idarubicin—Hypersensitivity—Dactinomycin—ocular cancer	0.000871	0.00526	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.000857	0.00472	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2C—ocular cancer	0.000838	0.00461	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—GNA11—ocular cancer	0.00083	0.00457	CbGpPWpGaD
Idarubicin—Diarrhoea—Dactinomycin—ocular cancer	0.000809	0.00489	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000793	0.00436	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.000787	0.00433	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00078	0.00429	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—GNAQ—ocular cancer	0.000772	0.00425	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.000764	0.0042	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.000764	0.0042	CbGpPWpGaD
Idarubicin—Vomiting—Dactinomycin—ocular cancer	0.000752	0.00454	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.000749	0.00412	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.000749	0.00412	CbGpPWpGaD
Idarubicin—Rash—Dactinomycin—ocular cancer	0.000746	0.0045	CcSEcCtD
Idarubicin—Nausea—Dactinomycin—ocular cancer	0.000703	0.00424	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle—E2F5—ocular cancer	0.000697	0.00384	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—HDAC1—ocular cancer	0.000696	0.00383	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.000688	0.00378	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—E2F4—ocular cancer	0.000683	0.00376	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.000683	0.00376	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.000679	0.00373	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000676	0.00372	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—E2F2—ocular cancer	0.00067	0.00369	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RBL1—ocular cancer	0.00067	0.00369	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00065	0.00357	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00065	0.00357	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00065	0.00357	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000642	0.00353	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000618	0.0034	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000617	0.0034	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RBL2—ocular cancer	0.000615	0.00338	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000604	0.00332	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000596	0.00328	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000589	0.00324	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—E2F3—ocular cancer	0.000581	0.0032	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.000581	0.0032	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00057	0.00313	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000558	0.00307	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.000552	0.00304	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000548	0.00301	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.00054	0.00297	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000514	0.00283	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND3—ocular cancer	0.00049	0.00269	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000486	0.00267	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000472	0.0026	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.000467	0.00257	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000434	0.00239	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000414	0.00228	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000408	0.00224	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000401	0.0022	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000388	0.00213	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDK6—ocular cancer	0.000365	0.00201	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00036	0.00198	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PSPH—ocular cancer	0.000354	0.00195	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000351	0.00193	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000351	0.00193	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000332	0.00183	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000329	0.00181	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000314	0.00173	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000314	0.00173	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND2—ocular cancer	0.000314	0.00173	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—HDAC1—ocular cancer	0.000314	0.00173	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000304	0.00167	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000289	0.00159	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000289	0.00159	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2B—ocular cancer	0.000281	0.00155	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SAG—ocular cancer	0.00028	0.00154	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—EP300—ocular cancer	0.000277	0.00153	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—E2F1—ocular cancer	0.000258	0.00142	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000252	0.00139	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000251	0.00138	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000249	0.00137	CbGpPWpGaD
Idarubicin—ABCC1—Disease—E2F5—ocular cancer	0.000248	0.00136	CbGpPWpGaD
Idarubicin—ABCC1—Disease—E2F4—ocular cancer	0.000243	0.00133	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RPL39—ocular cancer	0.000238	0.00131	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RBL1—ocular cancer	0.000238	0.00131	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000235	0.00129	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDK2—ocular cancer	0.000223	0.00122	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDK4—ocular cancer	0.00021	0.00116	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000207	0.00114	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	0.000205	0.00113	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	0.000198	0.00109	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TFDP1—ocular cancer	0.000192	0.00105	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RB1—ocular cancer	0.000183	0.00101	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000175	0.000961	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000159	0.000876	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PSPH—ocular cancer	0.000159	0.000872	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PSPH—ocular cancer	0.000157	0.000865	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MDM2—ocular cancer	0.000156	0.000858	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAML2—ocular cancer	0.000152	0.000838	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000152	0.000836	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000147	0.000809	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	0.000142	0.000784	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	0.00014	0.000769	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND1—ocular cancer	0.000136	0.000747	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	0.000131	0.000723	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—EP300—ocular cancer	0.000125	0.000688	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	0.000122	0.000671	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HDAC1—ocular cancer	0.000111	0.000613	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNA11—ocular cancer	0.000111	0.000612	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYC—ocular cancer	0.000109	0.0006	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNAQ—ocular cancer	0.000103	0.000569	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN2B—ocular cancer	9.98e-05	0.000549	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—ocular cancer	8.95e-05	0.000492	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.35e-05	0.000459	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MDM2—ocular cancer	5.54e-05	0.000305	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1B—ocular cancer	5.06e-05	0.000278	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNA11—ocular cancer	4.99e-05	0.000275	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNA11—ocular cancer	4.95e-05	0.000272	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1A—ocular cancer	4.67e-05	0.000257	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNAQ—ocular cancer	4.64e-05	0.000255	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNAQ—ocular cancer	4.6e-05	0.000253	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EP300—ocular cancer	4.44e-05	0.000244	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—ocular cancer	3.87e-05	0.000213	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TGFB1—ocular cancer	3.86e-05	0.000212	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—EP300—ocular cancer	3.72e-05	0.000205	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.71e-05	0.000204	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HRAS—ocular cancer	3.04e-05	0.000167	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT1—ocular cancer	2.68e-05	0.000148	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKT1—ocular cancer	2.25e-05	0.000124	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—EP300—ocular cancer	1.67e-05	9.17e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—EP300—ocular cancer	1.65e-05	9.09e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKT1—ocular cancer	1.01e-05	5.54e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKT1—ocular cancer	9.99e-06	5.49e-05	CbGpPWpGaD
